US$ 20.04
bpc 157 for inflammation Heal or Harm: Body Protective Compound-157 in the Gray Zone High-level overview of pathways modulated
Description
Retrieved March 30, 2018

However, there are no large clinical trials examining its safety or efficacy in autoimmune patients

Because NAD+ works through the bodys own energy and repair systems while peptides work through targeted signaling, the two cover a wide range of goals between them, which is a large part of why patients ask about both in the same visit

Patients search for relief beyond conventional drugs that often bring side effects
